Author

Wedemeyer H

March 6, 2018
Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe
Summary Hepatitis C virus (HCV) infection is a major public health problem in the European Union (EU). An estimated 5.6 million Europeans are chronically infected with a wide range of variation in prevalence across European Union countries. Although HCV continues to spread as a largely “silent pandemic,” its elimination is made possible through the availability […]

Read More
December 4, 2015
Estimating HCV disease burden – volume 3 (editorial)
Summary No abstract available. Countries: Estonia, Hungary, Iceland, Indonesia, Iran, Japan, Latvia, Lebanon, Lithuania, Pakistan, Romania, Saudi Arabia, Slovenia, South Korea, United Arab Emirates Read the Full Report

Read More
January 5, 2015
Estimates on HCV disease burden worldwide – filling the gaps
Summary Hepatitis C is caused by infection with the hepatitis C virus (HCV) and represents a major global health burden. Persistent HCV infection can lead to progressive liver disease with the development of liver cirrhosis and hepatocellular carcinoma, possibly accounting for up to 0.5 million deaths every year. Treatment of HCV infection is undergoing a […]

Read More
September 29, 2014
Response to letter to the editor: Strategies to reduce HCV disease burden and HCV transmission need different models, as what works for end‐stage liver disease may not work for HCV prevalence: a comment on the results presented in JVH Special Issue
Summary No abstract available. Countries: Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Egypt, England, France, Germany, Portugal, Spain, Sweden, Switzerland, Turkey Read the Full Report

Read More
May 5, 2014
Strategies to manage hepatitis C virus (HCV) disease burden
Summary The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis […]

Read More
May 5, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm
Summary The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modeling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, […]

Read More
May 5, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Summary Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New treatment options are becoming available, and there is a need to characterize the epidemiology and disease burden of HCV. Data for prevalence, viremia, genotype, diagnosis and treatment were obtained through literature searches and expert consensus for 16 countries. For […]

Read More